FDA hearing: psychedelics launch needs balanced regulation without limiting access

Summary

The FDA has prioritized psychedelic treatments following an Executive Order aimed at accelerating research and regulatory pathways. The agency is holding a hearing to establish balanced regulation that promotes access to psychedelic treatments.